WuXi Biologics wins at 2026 Asia-Pacific Biopharma Excellence Awards for leadership in bioprocessing, manufacturing excellence, and digital innovation

Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion

SportsMed Physical Therapy named Physical Therapy Company of the Year

Ensorcell adds new senior leadership team members

GelMEDIX completes USD13m seed financing, announces first partnership

AmacaThera named Life Sciences Ontario Emerging Company of the Year

GenSight Biologics reports first patient treated in GS010 REVISE study

Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme

OncoHost receives BIG Innovation Award in Health category

Zydus Lifesciences acquires Agenus Inc's biologics manufacturing facilities, launches Zylidac Bio LLC in US

MemorialCare hospitals recognised in 2026 Women's Choice Awards

Champions Oncology expands bioanalytical services with new technology and leadership

Kedrion's investigational treatment for Congenital Aceruloplasminemia receives European Orphan Drug Designation

PhaseV receives three industry honours for AI in clinical development

Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation